Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

由 Vanneste, Ben G. L., Van Limbergen, Evert J., van Lin, Emile N., van Roermund, Joep G. H., Lambin, Philippe
發表在 Biomed Res Int (2016)

Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?

由 Vanneste, Ben G.L., Van Limbergen, Evert J., Marcelissen, Tom, Reynders, Kobe, Melenhorst, Jarno, van Roermund, Joep G.H., Lutgens, Ludy
發表在 Clin Transl Radiat Oncol (2021)

Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness

由 van Roermund, Joep G. H., Bol, Gijsbert H., Alfred Witjes, J., Ruud Bosch, J. L. H., Kiemeney, Lambertus A., van Vulpen, Marco
出版 2009

Phenotype plasticity rather than repopulation from CD90/CK14+ cancer stem cells leads to cisplatin resistance of urothelial carcinoma cell lines

由 Skowron, Margaretha A., Niegisch, Günter, Fritz, Gerhard, Arent, Tanja, van Roermund, Joep G. H., Romano, Andrea, Albers, Peter, Schulz, Wolfgang A., Hoffmann, Michèle J.
發表在 J Exp Clin Cancer Res (2015)

Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines

由 Skowron, Margaretha A., Melnikova, Margarita, van Roermund, Joep G. H., Romano, Andrea, Albers, Peter, Thomale, Jürgen, Schulz, Wolfgang A., Niegisch, Günter, Hoffmann, Michèle J.
發表在 Int J Mol Sci (2018)

Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer

由 Kok, Dieuwertje E. G., van Roermund, Joep G. H., Aben, Katja K., van de Luijtgaarden, Moniek W. M., Karthaus, Herbert F. M., van Vierssen Trip, Oncko B., Kampman, Ellen, Alfred Witjes, J., Kiemeney, Lambertus A. L. M.
出版 2010